Legal Opinion
Kader v. Sarepta Therapeutics, Inc.
Court of Appeals for the First Circuit
Decided April 4, 2018No. 17-1139PPublishedCited by 56 opinions
1Opinion of the Court
TORRUELLA, Circuit Judge.
Plaintiff William Kader and Lead Plaintiffs Morad Ghodooshim, Roger Lam, and Laxmikant Chudasama (collectively, the "Plaintiffs") sought to represent a class of purchasers of securities that Sarepta Therapeutics, Inc. ("Sarepta") issued between April 21, 2014, and October 27, 2014 (the "Class Period"). The Plaintiffs brought securities fraud claims against Sarepta, Sarepta's Chief Executive Officer, Christopher Garabedian ("Garabedian"), and Sarepta's Chief Scientific Officer, Edward M. Kaye ("Kaye") (collectively, the "Defendants"). According to the Plaintiffs, the…
2Cases cited17 opinions
- Foman v. DavisSupreme Court of the United States · 1962
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Greebel v. FTP Software, Inc.Court of Appeals for the First Circuit · 1999
- In Re Advanta Corp. Securities LitigationCourt of Appeals for the Third Circuit · 1999
- Steir v. Girl Scouts of the USACourt of Appeals for the First Circuit · 2004
12 more not listed; retrieve them via the Exa API.
3Cited by56 opinions
- Amyndas Pharmaceuticals, S.A. v. Zealand Pharma A/SCourt of Appeals for the First Circuit · 2022
- Yan v. ReWalk Robotics Ltd.Court of Appeals for the First Circuit · 2020
- Constr. Industry and Laborers Joint Pension Trust v. Carbonite, Inc.Court of Appeals for the First Circuit · 2021
- In Re: Ocular Therapeutix Inc v.Court of Appeals for the First Circuit · 2020
- Shash v. Biogen Inc.Court of Appeals for the First Circuit · 2023
51 more not listed; retrieve them via the Exa API.